Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Benzodiazepines and medications acting on benzodiazepine receptors that do not have a benzodiazepine structure (z-drugs) have been viewed by some experts and regulatory bodies as having limited benefit and significant risks. Data presented in this article support the use of these medications as treatments of choice for acute situational anxiety, chronic anxiety disorders, insomnia, alcohol withdrawal syndromes, and catatonia. They may also be useful adjuncts in the treatment of anxious depression and mania, and for medically ill patients. Tolerance develops to sedation and possibly psychomotor impairment, but not to the anxiolytic effect of benzodiazepines. Sedation can impair cognitive function in some patients, but assertions that benzodiazepines increase the risk of dementia are not supported by recent data. Contrary to popular opinion, benzodiazepines are not frequently misused or conduits to misuse of other substances in patients without substance use disorders who are prescribed these medications for appropriate indications; most benzodiazepine misuse involves medications that are obtained from other people. Benzodiazepines are usually not lethal in overdose except when ingested with other substances, especially alcohol and opioids. Benzodiazepines comprise one of the few classes of psychotropic medication the mechanisms of action of which are clearly delineated, allowing for greater precision in their clinical use. These medications, therefore, belong in the therapeutic armamentarium of the knowledgeable clinician.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After several decades of use, Benzodiazepines and Benzodiazepine Receptor Agonists remain important therapeutic options for the treatment of mental health related concerns such as anxiety and sleep disorders.1”
Citations
Cites
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Penninx, B. W., Pine, D. S., Holmes, E. A., & Reif, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00359-7 · Cited by 740
Tromp, A. M., Pluijm, S. M. F., Smit, J. H., Deeg, D. J. H., Bouter, L. M., & Lips, P. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00349-3 · Cited by 666
Drug–drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Geffrey, A. L., Pollack, S. F., Bruno, P. L., & Thiele, E. A. (2015) · Epilepsia · doi:10.1111/epi.13060 · Cited by 496
Slee, A., Nazareth, I., Bondaronek, P., Liu, Y., Cheng, Z., & Freemantle, N. (2019) · The Lancet · doi:10.1016/s0140-6736(18)31793-8 · Cited by 372
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Dolovich, L. R., Addis, A., Vaillancourt, J. M. R., Power, J. D. B., Koren, G., & Einarson, T. R. (1998) · BMJ · doi:10.1136/bmj.317.7162.839 · Cited by 353
The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
Ravindran, L. N., & Stein, M. B. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06218blu · Cited by 317
Paradoxical reactions to benzodiazepines: literature review and treatment options
Mancuso, C. E., Tanzi, M. G., & Gabay, M. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1177.38089 · Cited by 298
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Research works printed but not linked: 1
- 10.1080/15622975.2018.1500031 · DOI · Paper page
Cited by
Hirjak, D., Rogers, J. P., Wolf, R. C., Kubera, K. M., Fritze, S., Wilson, J. E., Sambataro, F., Fricchione, G. L., Meyer‐Lindenberg, A., Ungvari, G. S., et al. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00534-w · Cited by 106
Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview
Alshial, E. E., Abdulghaney, M. I., Wadan, A. S., Abdellatif, M. A., Ramadan, N. E., Suleiman, A. M., Waheed, N., Abdellatif, M., & Mohammed, H. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122257 · Cited by 98
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
Huang, J., Huang, W., Yi, J., Deng, Y., Li, R., Chen, J., Shi, J., Qiu, Y., Wang, T., Chen, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43150-0 · Cited by 81
Ngcobo, N. N. (2025) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01466-0 · Cited by 199
GABAergic implications in anxiety and related disorders
Arora, I., Mal, P., Arora, P., Paul, A., & Kumar, M. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150218 · Cited by 83
A review on the chemistry and pharmacological properties of benzodiazepine motifs in drug design
Tolu-Bolaji, O. O., Sojinu, S. O., Okedere, A. P., & Ajani, O. O. (2022) · Arab Journal of Basic and Applied Sciences · doi:10.1080/25765299.2022.2117677 · Cited by 51
Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey
Ritvo, A. D., Foster, D. E., Huff, C., Finlayson, A. J. R., Silvernail, B., & Martin, P. R. (2023) · PLOS ONE · doi:10.1371/journal.pone.0285584 · Cited by 38
Sharma, A., & Kumar, A. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13690 · Cited by 38
Højlund, M., Gudmundsson, L. S., Andersen, J. H., Saastamoinen, L., Zoëga, H., Skurtveit, S. O., Wastesson, J. W., Hallas, J., & Pottegård, A. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13811 · Cited by 42
Chang, Y., Xie, X., Liu, Y., Liu, M., & Zhang, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116329 · Cited by 44
Chan, A. Y. L., Gao, L., Howard, L. M., Simonoff, E. A., Coghill, D., Ip, P., Lau, W. C. Y., Taxis, K., Wong, I. C. K., & Man, K. K. C. (2023) · Psychotherapy and Psychosomatics · doi:10.1159/000529141 · Cited by 35
Rosenqvist, T. W., Wium‐Andersen, M. K., Wium‐Andersen, I. K., Jørgensen, M. B., & Osler, M. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230075 · Cited by 40
Dissociative seizures in the emergency room: room for improvement
Cengiz, O., Jungilligens, J., Michaelis, R., Wellmer, J., & Popkirov, S. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332063 · Cited by 36
Bae, G. Y., Ahn, Y., Hong, K., Jung, E.-J., Suh, H. J., & Jo, K. (2023) · Foods · doi:10.3390/foods12152864 · Cited by 25
Zhang, S.-R., Wu, D., Luo, R., Wu, J., Chen, H., Li, Z.-M., Zhuang, J.-P., Hu, N.-Y., Li, X., Yang, J., et al. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.2103-23.2024 · Cited by 27
Kisielewska, W., Kościółek, M., Kowalczyk, W., Mitura, B., Mitura, L., Rogula, S., Leszczyński, P., Antosik, K., & Mitura, K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092940 · Cited by 38
Hou, J.-H., Sun, S.-L., Tan, C.-C., Huang, Y., Tan, L., & Xu, W. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.78 · Cited by 21
Hasan, M. S. A., Bhuia, M. S., Chowdhury, R., Husain, Z., Saifuzzaman, M., Mia, E., Akbor, M. S., Yana, N. T., Islam, M. A., Ansari, S. A., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.004 · Cited by 21
The function of sleep and the treatment of primary insomnia
Freund, W., & Weber, F. (2023) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2023.0228 · Cited by 21
Doraghi, F., Gilaninezhad, F., Karimian, S., Mahdavian, A. M., Larijani, B. A., & Mahdavi, M. R. (2024) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202301164 · Cited by 17
Meneses, C., Valdés, M., Garrido‐Suárez, B. B., & Garrido, G. (2023) · Phytotherapy Research · doi:10.1002/ptr.7830 · Cited by 20
Incidence and impacts of post-cardiac event mental health problems
Murphy, B. M., Higgins, R. O., & Jackson, A. C. (2023) · Australian Journal of General Practice · doi:10.31128/ajgp-05-23-6828 · Cited by 16
Sikirić, P., Blagaić, A. B., Štrbe, S., Orešković, L. B., Orešković, I., Sikirić, S., Starešinić, M., Sever, M., Kokot, A., Jurjević, I., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17040461 · Cited by 19
Campos-Prieto, L., García-Rey, A., Sotelo, E., & Mallo‐Abreu, A. (2024) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.20.261 · Cited by 19
Soumerai, S. B., Shahzad, M., & Salzman, C. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240030 · Cited by 18
Saddik, R., Brandán, S. A., Mortada, S., Baydere, C., Roby, O., Dege, N., Tighadouini, S., Tahiri, M., Faouzi, M. E. A., & Karrouchi, K. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.135283 · Cited by 15
Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
Modesto‐Lowe, V., Chaplin, M., León-Barriera, R., & Jain, L. (2024) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.91a.23061 · Cited by 24
SARM1 deficiency induced depressive-like behavior via AMPKα/p-eEF2 axis to synapse dysfunction
Li, W., Zhu, W., Chen, J., Ali, T., & Li, S. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110206 · Cited by 13
Flores-Bazán, T., Cabrera, G. B., Guerrero-Solano, J. A., Negrete‐Díaz, J. V., Germán-Ponciano, L. J., & Olivo, D. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148554 · Cited by 15
Biomarkers of cognitive and memory decline in psychotropic drug users
Grigore, M. M., Ruscu, M. A., Hermann, D. M., Colita, I.-C., Doeppner, T. R., Glăvan, D., & Popa‐Wagner, A. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02837-4 · Cited by 12
Stigmatization of Benzodiazepines: Pharmacologic and Nonpharmacologic Contributions
Silberman, E. K. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000525208 · Cited by 14
IUPHAR review: Moving beyond dopamine-based therapeutic strategies for schizophrenia
Moran, P. M., & Granger, K. T. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107727 · Cited by 13
Revisiting benzodiazepines (GABA Enhancers):A transdiagnostic and precision medicine approach
Pallanti, S., Zohar, J., Kasper, S. F., Möller, H., & Hollander, E. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.11.042 · Cited by 15
Wisłowska-Stanek, A., Jarkiewicz, M., & Mirowska-Guzel, D. M. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00689-z · Cited by 18
Gómez, L. C. G., Medina, N. B., Blasco, S. S., & Gravielle, M. C. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137358 · Cited by 15
Nardi, A. E., & Quagliato, L. A. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524730 · Cited by 14
Effects of Ketamine vs. Midazolam in Adolescent Treatment Resistant Depression
Macejova, A., Kovacova, V., Tonhajzerová, I., Višňovcová, Z., Ferencová, N., Mlyncekova, Z., Kukucka, T., & Ondrejka, I. (2024) · Pharmaceuticals · doi:10.3390/ph17121627 · Cited by 10
Incident Benzodiazepine and Z-Drug Use and Subsequent Risk of Serious Infections
Wang, X., Isomura, K., Lichtenstein, P., Kuja‐Halkola, R., D'Onofrio, B. M., Brikell, I., Quinn, P. D., Zhu, N., Jayaram‐Lindström, N., Chang, Z., et al. (2024) · CNS Drugs · doi:10.1007/s40263-024-01108-w · Cited by 11
Zhou, C., Hu, Y.-F., Zhang, Y., Wang, C., Liao, X.-J., Cheng, F., & Jiang, Y. (2023) · Food Research International · doi:10.1016/j.foodres.2024.114737 · Cited by 8
Fu, S., Wang, B., Li, Y.-C., Huang, Z. L., Shi, Z.-W., Zuo, G., Zhao, J., Xu, H.-J., & Wang, M. (2025) · Microchimica Acta · doi:10.1007/s00604-024-06912-1 · Cited by 7
Stapel, B., Alvarenga, M. E., & Kahl, K. G. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1490585 · Cited by 8
Niazi, N. U. K., Jiang, J., Ou, H., Chen, R., & Yang, Z. (2025) · Brain Sciences · doi:10.3390/brainsci15060641 · Cited by 9
Silberman, E. K., Nardi, A. E., Starčević, V., Balon, R., Cosci, F., Fava, G. A., Salzman, C., Shader, R. I., & Sonino, N. (2023) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23com14959 · Cited by 9
Rethinking the medication management of major depression
Mann, J. J., & Rizk, M. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2190886 · Cited by 10
Unger, C., & Kohlmeier, K. A. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.108743 · Cited by 8
Peng, Z., Zheng, Y., Yang, Z., Zhang, H., Li, Z., Xu, M., Cui, S., & Lin, R. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1341072 · Cited by 8
Chahal, S., Rani, P., Singh, R., Joshi, G., Kumar, R., Kumar, P. P., Wadhwa, D., Singh, D., & Sindhu, J. (2024) · Future Medicinal Chemistry · doi:10.1080/17568919.2024.2400968 · Cited by 6
Lahijani, S., Rueda-Lara, M. A., McAndrew, N. S., Nelson, A. M., Guo, M., Knight, J. M., Wiener, L. S., Miran, D. M., Gray, T. F., Keane, E. P., et al. (2024) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2024.05.024 · Cited by 8
The role of benzodiazepines in common conditions: a narrative review focusing on lormetazepam
Pallanti, S. (2024) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000529 · Cited by 7
Meng, W., Mingqiang, W., Junyang, Z., Bin, P., Wu, Q., & Chao, W. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1663585 · Cited by 8
Benefits and Liabilities of Benzodiazepines and Z-Drugs: What We Know and What We Don’t Know
Silberman, E. K. (2025) · Drugs · doi:10.1007/s40265-025-02261-2 · Cited by 8
Benzodiazepines at the crossroads: navigating therapeutic promise and perils of misuse
Figg, J., Love, C., Sorathia, V., Engelbart, M. K., Turner, A., & Elton, A. (2026) · Annals of General Psychiatry · doi:10.1186/s12991-025-00627-0 · Cited by 5
Koniuszewski, F., Vogel, F. D., Dajic, I., Seidel, T., Kunze, M., Willeit, M., & Ernst, M. C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1188101 · Cited by 8
Fernandes, H., Novais, C., Sousa‐Pinto, B., Soares-da-Silva, P., & Azevedo, L. F. (2025) · Psychotherapy and Psychosomatics · doi:10.1159/000546269 · Cited by 7
Management of unspecified anxiety disorder: Expert consensus
Sakurai, H., Inada, K., Aoki, Y., Takeshima, M., Ie, K., Kise, M., Yoshida, E., Tsuboi, T., Yamada, H., Hori, H., et al. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12323 · Cited by 7
Neural Network Excitation/Inhibition: A Key to Empathy and Empathy Impairment
Tang, Y., Wang, C., Li, Q., Liu, G., Song, D. F., Quan, Z., Yan, Y., & Qing, H. (2024) · The Neuroscientist · doi:10.1177/10738584231223119 · Cited by 9
A detox dilemma beyond benzodiazepines; clonidine's quandary in alcohol withdrawal management
Johnson, M. J., Cosentino, D., & Fuehrlein, B. (2024) · American Journal on Addictions · doi:10.1111/ajad.13640 · Cited by 5
Ochi, S., Tsuboi, T., Hasegawa, N., Hori, H., Ichihashi, K., Imamura, Y., Okada, T., Kodaka, F., Saito, Y., Iga, J., et al. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12499 · Cited by 4
Krieger, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1569416 · Cited by 7
Wang, Y., Wu, Y., Wang, R., Wang, Z., & Luo, F. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1507639 · Cited by 5
New Trends in the Methodologies of Determination of Benzodiazepine Residues in Biological Samples
Ibarra, I. S., Vázquez-Garrido, I., Islas, G., & Flores-Aguilar, J. F. (2025) · Separations · doi:10.3390/separations12040095 · Cited by 4
Anti-anxiety and Hypnotic Effects of Lawsonia inermis Hydroalcoholic Extract
Pourbagher‐Shahri, A. M., Rakhshandeh, H., Sabahi, K., Hosseini, M., & Forouzanfar, F. (2023) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666230119162349 · Cited by 4
Lappas, A. S., Helfer, B., Henke‐Ciążyńska, K., Samara, M. T., & Christodoulou, G. N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12185801 · Cited by 6
Endo, H., Shigetsura, Y., Tsurumi, K., Sugita, N., Nakagawa, S., Imai, S., & Terada, T. (2025) · Cureus · doi:10.7759/cureus.77936 · Cited by 3
Solvent-induced photophysical properties and stability of clonazepam and Chlordiazepoxide
kian, R., Zakerhamidi, M. S., & Merajin, Z. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-30955-w · Cited by 3
Differential effects of clonazepam on declarative memory formation and face recognition
León, C. S., Celso, A. L., Benítez, F. A. U., Bonilla, M., Olivar, N., Toledo, J., Brusco, L. I., & Forcato, C. (2024) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2024.107956 · Cited by 3
Aupperle, R. L., Berg, H. E., & Armstrong, J. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_549 · Cited by 3
Hu, J., Zhao, Y., Shao, L., Zhang, W., Wang, H., Liu, Y., Su, M., & Zuo, X. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70130 · Cited by 7
The Blurred Lines Between New Psychoactive Substances and Potential Chemical Weapons
Valenzuela-Tapia, L. N., Quintul, C. A., Concha-Rubio, N. D., Toledo-Ríos, L., Salas-Kuscevic, C., Leisewitz, A. V., Cámpora-Oñate, P., & Campanini-Salinas, J. (2025) · Toxics · doi:10.3390/toxics13080659 · Cited by 6
Chapoutot, M., Meloni, F., Peter‐Derex, L., Bastuji, H., Leslie, W., Schoendorff, B., Heinzer, R. C., Nicolas, A., Higgins, S., Bourgeois, A., et al. (2025) · Journal of Behavioral and Cognitive Therapy · doi:10.1016/j.jbct.2025.100533 · Cited by 6
Achour, V., Faugère, M., Maakaron, É., Gavat, J., Fond, G. B., Lançon, C., & Korchia, T. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.10098 · Cited by 3
Harm reduction approaches for the use of benzodiazepines: a scoping review
Morrison, C., Natale, I., Branchflower, A., Harvey, C., & Lundin, R. M. (2025) · Harm Reduction Journal · doi:10.1186/s12954-025-01310-z · Cited by 2
Zeng, Z., Liu, Z., Zhao, Y., Lin, C., Weng, Q., Lin, X., Wang, J., & Cai, Z. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.115658 · Cited by 2
Rodrigues‐Ribeiro, L., Resende, B. L., Dias, M. L. P., Lopes, M. R., de Barros, L. L. M., Moraes, M. A., Verano‐Braga, T., & Souza, B. R. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-50624-6_6 · Cited by 4
Unusual presentation of benzodiazepine withdrawal with Takotsubo syndrome: a case report
Campos, I. D., Moreira, H., Portal, F., & Paiva, J. A. (2024) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytae136 · Cited by 2
Fogelson, D. L. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000527817 · Cited by 2
Correlation analysis between insomnia symptoms and language function in patients with schizophrenia
Linlin, W., Ruofei, J., Hudan, C., Ruxuan, T., & Yao, J. (2023) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2023.100292 · Cited by 2
Benzodiazepines in elderly patients
Fava, G. A. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13619 · Cited by 4
Melcarne, R., Bernasconi, S., Prete, M. D., Artizzu, S., Guttmann, S., Ciprandi, G., & Gemignani, A. (2025) · Panminerva Medica · doi:10.23736/s0031-0808.25.05330-3 · Cited by 2
Iancu, L., Wellens, M., & Sahlean, T. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-05766-8 · Cited by 1
Muenks, A., Farrell, D. P., Zhou, G., & DiMaio, F. (2025) · Structure · doi:10.1016/j.str.2025.07.002 · Cited by 1
Wang, X., Chang, Z., Molero, Y., Isomura, K., de la Cruz, L. F., Lichtenstein, P., Kuja‐Halkola, R., D'Onofrio, B. M., Quinn, P. D., Larsson, H., et al. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251373069 · Cited by 2
Rathee, S., Sen, D., Jain, A., & Jain, S. K. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04887-1 · Cited by 3
The Rationale for, and Use of, Benzodiazepines in Cardiac Conditions
Rustad, J. K., Braford, M. B., Ho, P. A., Chen, K., Pavisian, B., Kasick, D. P., & Stern, T. A. (2026) · Psychiatric annals · doi:10.3928/00485713-20251202-04 · Cited by 1
Time Trends in Prescribing of Anxiolytic, Sedative, and Hypnotic Drugs in the United States
Yang, Z., Shader, R. I., & Greenblatt, D. J. (2026) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.12.014 · Cited by 4
Anjum, R., Khalid, N., Musaddaq, R., Tariq, A., Jamil, M., Afzal, S., & Anjum, S. (2024) · Neurophysiology · doi:10.1007/s11062-025-09987-5 · Cited by 2
Liu, E., Wang, C., Wang, X., Liu, K., Qin, S., Lin, L., Li, J., Xu, M., Liu, C., Wu, H., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1782826 · Cited by 4
Li, X.-L., Huang, W.-T., Ni, X., Lu, H., Huang, S.-Q., Li, Y., Xie, H.-S., Yu-guan, W., Wang, Z.-Z., & Shang, D. (2026) · ALPHA PSYCHIATRY · doi:10.31083/ap38973 · Cited by 1
Re-evaluating benzodiazepines for anxiety disorders – déjà-vu all over again?
Anderson, I. M. (2023) · BJPsych Advances · doi:10.1192/bja.2022.85 · Cited by 1
Benzodiazepines: Kamo griadeshi?
Golovenko, M. Y. (2023) · JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE · doi:10.37621/jnamsu-2023-1-2-8 · Cited by 3
Clinical practice for unspecified anxiety disorder in primary care
Sakurai, H., Takeshima, M., Inada, K., Aoki, Y., Ie, K., Kise, M., Yoshida, E., Tsuboi, T., Yamada, H., Hori, H., et al. (2023) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.118 · Cited by 2
Protocolo terapéutico de uso de benzodiacepinas y antipsicóticos
Abellán, C. M., Rojo, S. F., Álvarez-Mon, M. Á., & Mora, F. (2023) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2023.08.007 · Cited by 3
Viana, H. K. M. M. C., Oliveira, G. L. D. S., Moreno, L. C. G. E. A. I., Cavalcante, A. A. D. C. M., do Amaral, M. P. D. M., Arcanjo, D. D. R., & Rolim, H. M. L. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173654 · Cited by 1
Analysis and Evaluation of Prospects for the Development of New Drugs Derived from Benzodiazepines
Porseva, N. Y., Собин, Ф. В., Солонинина, А. В., Пулина, Н. А., Курбатов, Е. Р., & Dvorskaya, O. N. (2023) · Drug development & registration · doi:10.33380/2305-2066-2023-12-4(1)-1639 · Cited by 1
DANO TEMPORAL DO USO DE BENZODIAZEPÍNICOS POR IDOSOS: REVISÃO BIBLIOGRÁFICA
da Silva, C. F., Raimundo, M. D. M., Miranda, R. L., Soprani, T., & Ronchi, S. N. (2024) · Revista Contemporânea · doi:10.56083/rcv4n6-115 · Cited by 2
Mayasa, V., Rebecca, R., Patil, A. S., Gandla, K., Nelson, V. K., & Repudi, L. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00404 · Cited by 3
Aminu, I., Oladeji, K. F. L., Lawal, A. T., Ajibola, O. E., Chengetanai, S., Ajibola, M. I., Ibrahim, A., & Ajao, M. S. (2024) · üha · doi:10.32739/uha.jnbs.11.1538964 · Cited by 1
Prottay, A. A. S., ., E., Ripu, T. R., Sarwar, M. N., Rahman, T., Ahmmed, M. S., Bappi, M. H., Emon, M., Ansari, S. A., Coutinho, H. D. M., et al. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115392 · Cited by 1
Sex differences in the pharmacotherapy of neurological patients
Čorić, L., Gadže, Ž. P., Hodžić, A., Bošnjak, J., & Papić, K. (2025) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-025-00990-5 · Cited by 1
Metadata
- Authors
- Dubovsky, S. L., & Marshall, D.
- Affiliations
- University of Colorado Anschutz (US)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2022
- Volume
- 91
- Issue
- 5
- Pages
- 307-334
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W4225388848
- Cited by
- 171
- References
- 105
- Citations by year
- 2026: 40 · 2025: 44 · 2024: 41 · 2023: 38 · 2022: 8
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- benzodiazepines, Z-drugs, anxiety disorders, insomnia, alcohol withdrawal, catatonia, anxious depression, mania, sedation, tolerance (pharmacology and immunology), cognitive impairment, dementia risk, benzodiazepine misuse, benzodiazepine overdose, benzodiazepine receptor, mechanism of action
- MeSH terms
- Alcoholism, Anxiety, Benzodiazepines, Humans, Substance Withdrawal Syndrome, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.